The expression of GPSM2 was also found to be significantly associated with high levels of immune cell infiltration in gastrointestinal cancers; however, no significant correlation was detected between GPSM2 expression and survival rates or immune cell infiltration in CRC. Here, GPSM2 is linked to colorectal carcinoma.